NEXGEL, INC. (NXGLW)

↓ Download CSV

CIK 0001468929 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, NEXGEL, INC. reported revenue of $11.42M, up 31.5% from the prior year. The company ran a net loss, with a net margin of -26.3% and a gross margin of 39.5%. It held $10.46M in total assets against $5.57M in total liabilities.

Key ratios (FY2025)

39.5%
Gross margin
-29.3%
Operating margin
-26.3%
Net margin
-67.3%
Return on equity
+31.5%
Revenue growth (YoY)
Metric (FY)202520242023202220212020201920182017
Revenue$11.42M$8.69M$4.09M$2.05M$1.55M$674.0K$717.0K$2.21M
Cost of Revenue$6.91M$5.94M$3.71M$1.79M$1.54M$965.0K$854.0K$1.70M
Gross Profit$4.51M$2.75M$374.0K$256.0K$8.0K-$291.0K-$137.0K$514.0K
Operating Income-$3.35M-$3.55M-$3.48M-$3.35M-$2.57M-$2.26M-$1.92M-$1.89M
Net Income-$3.00M-$3.28M-$3.16M-$4.75M-$4.31M-$2.26M-$1.92M-$1.89M
EPS (Diluted)$-0.38$-0.50$-0.56$-0.85$-1.45$-1.05$-0.14$-0.38
Total Assets$10.46M$10.98M$9.96M$10.36M$16.98M$2.26M$1.89M$739.0K
Total Liabilities$5.57M$4.90M$4.79M$2.72M$4.90M$2.19M$1.51M$458.0K
Shareholders' Equity$4.46M$5.75M$4.70M$7.64M$12.09M$71.0K$380.0K$281.0K$625.0K
Cash & Equivalents$13.35M$32.0K$261.0K$0
Operating Cash Flow-$1.31M-$3.87M-$3.24M-$2.99M-$2.75M-$1.80M-$1.81M-$1.54M
Capital Expenditures$68.0K$443.0K$696.0K$96.0K$269.0K$312.0K$0
Shares Outstanding8.14M7.64M5.74M5.58M5.57M2.84M57.51M57.51M